Abstract
Utilising biomarkers for COVID-19 diagnosis, prediction of treatment response and overall prognostication have been investigated recently. However, these ventures have only considered the use of blood-based molecular markers. Saliva is another biofluid that warrants being applied in similar fashion with major advantages that centres on its non-invasive and repeatable collection as well as cost-efficiency. To this end, this article presents a hypothesis for the sources of biomarkers useful clinically for COVID-19 disease outcome estimation and identify the likely implications of their detection in saliva.
All Keywords
【저자키워드】 SARS-CoV-2, COVID-19 pandemic, Saliva biomarkers, 【초록키워드】 Saliva, Biomarker, outcome, COVID-19 disease, COVID-19 diagnosis, molecular, Hypothesis, Non-invasive, Treatment response, implication, identify, investigated, clinically, applied, 【제목키워드】 Biomarker, Hypothesis, salivary,
【저자키워드】 SARS-CoV-2, COVID-19 pandemic, Saliva biomarkers, 【초록키워드】 Saliva, Biomarker, outcome, COVID-19 disease, COVID-19 diagnosis, molecular, Hypothesis, Non-invasive, Treatment response, implication, identify, investigated, clinically, applied, 【제목키워드】 Biomarker, Hypothesis, salivary,